Under the deal, the company will receive an upfront payment of US$10 million and is eligible for success-based milestones totalling up to US$330 million plus tiered royalties. …
Australian company partners to take innovative therapy to Asia
June 17, 2026 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Australian company partners to take innovative therapy to Asia
June 17, 2026 - - Latest News -
Novartis names interim leader for Australia and NZ after Country President departs
June 17, 2026 - - Latest News -
These outcomes are mostly about the choices Australia is making
June 17, 2026 - - Latest News -
AstraZeneca confirms pricing the issue, and acts to create a patient access program
June 16, 2026 - - Latest News -
When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution
June 16, 2026 - - Latest News -
Entropy Neurodynamics clears safety hurdle for IV psilocin trial in binge eating disorder
June 15, 2026 - - Australian Biotech -
Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment
June 15, 2026 - - Australian Biotech